O'Neill M F, Dourish C T, Tye S J, Iversen S D
Merck Sharp and Dohme Research Laboratory, Neuroscience Research Centre, Harlow, Essex U.K.
Brain Res. 1990 Nov 26;534(1-2):287-90. doi: 10.1016/0006-8993(90)90141-w.
The potential antinociceptive effects of the selective cholecystokinin-B (CCK-B) antagonist L-365,260 were examined in the squirrel monkey tail withdrawal test. Pain threshold was measured in 6 male monkeys by recording the latency to remove the tail from a warm (55 degrees C) water bath. L-365,260 at doses of 100 ng/kg to 100 micrograms/kg significantly elevated tail withdrawal latencies throughout a 2 h test period. These data provide the first evidence that blockade of CCK-B receptors induces analgesia in primates.
在松鼠猴甩尾试验中研究了选择性胆囊收缩素-B(CCK-B)拮抗剂L-365,260的潜在抗伤害感受作用。通过记录6只雄性猴子将尾巴从温水(55摄氏度)浴中移开的潜伏期来测量疼痛阈值。在2小时的试验期内,剂量为100纳克/千克至100微克/千克的L-365,260显著延长了甩尾潜伏期。这些数据首次证明CCK-B受体的阻断可在灵长类动物中诱导镇痛作用。